Austin Muranaka
Foot & Ankle Surgery · Vincennes, INNPI 1316219819
Payments from drug & device makers
Across 189 payments — averaging $48.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$4K
- Organogenesis Inc.$2K
- Stryker$2K
- AbbVie$576
- Mimedx Group, Inc.$429
- Integra Lifesciences Corporation$257
- plus $798 from 16 others
What the payments were for
- Consulting fees$2,37326%
- Travel & lodging$2,10023%
- Food & beverage$4,68551%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 15 | $3,646 |
| Organogenesis Inc. | 71 | $1,893 |
| Stryker | 18 | $1,557 |
| AbbVie | 27 | $576 |
| Mimedx Group, Inc. | 21 | $429 |
| Integra Lifesciences Corporation | 7 | $257 |
| KCI USA, Inc. | 6 | $171 |
| Paragon 28, Inc. | 4 | $149 |
| Aroa Biosurgery Incorporated | 2 | $132 |
| Polynovo North America LLC | 3 | $80 |
| Johnson & Johnson | 2 | $34 |
| Hartmann USA, Inc. | 2 | $33 |
| Averitas Pharma Inc. | 1 | $27 |
| Merck | 2 | $26 |
| Novo Nordisk | 1 | $26 |
| Vertex | 1 | $25 |
| Convatec Inc. | 1 | $23 |
| Nevro Corp. | 1 | $18 |
| Biocomposites Inc | 1 | $15 |
| Solventum Corporation | 1 | $15 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Orthofix Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Grafix$3,415
- Oasis$3,415
- GRAFIX PL$2,373
- Grafix XC$2,373
- ORTHOLOC 3DI$714
- PROstep$237
- PURAPLY WOUND MATRIX$148
- ORTHOLOC 2 LAPIFUSE$124
How this compares
$9,157 in reported general payments places this provider in the 70th percentile of 212 foot & ankle surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 92 | $835 |
| Pregabalin | 19 | $505 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 43 | $263 |
| Minocycline Hcl | 26 | $253 |
| Cephalexin | 30 | $138 |
| Methylprednisolone | 19 | $85 |
| Ciprofloxacin Hcl | 13 | $65 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Vincennes
- Steven HerbstMuncie$1.6M
- Douglas BlacklidgeKokomo$689K
- Patrick DeheerIndianapolis$493K
- Scott NevilleMooresville$353K
- Travis MontgomeryWestfield$345K
- Robert Clemency IiiSchererville$215K
- William AdamsGreenfield$178K
- Christopher WintersCarmel$158K
- Steven DouthettFort Wayne$153K
- Brian ElliottShelbyville$142K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.